High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor
The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the hum...
Saved in:
| Published in | Journal of medicinal chemistry Vol. 43; no. 7; pp. 1329 - 1338 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
WASHINGTON
American Chemical Society
06.04.2000
Amer Chemical Soc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-2623 1520-4804 |
| DOI | 10.1021/jm991129q |
Cover
| Abstract | The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure−activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors. |
|---|---|
| AbstractList | The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure−activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors. The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors. The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors.The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors. |
| Author | Adam, Geo Röver, Stephan Jenck, François Wichmann, Jürgen Dautzenberg, Frank M Galley, Guido Cesura, Andrea M Monsma, Frederick J |
| Author_xml | – sequence: 1 givenname: Stephan surname: Röver fullname: Röver, Stephan – sequence: 2 givenname: Geo surname: Adam fullname: Adam, Geo – sequence: 3 givenname: Andrea M surname: Cesura fullname: Cesura, Andrea M – sequence: 4 givenname: Guido surname: Galley fullname: Galley, Guido – sequence: 5 givenname: François surname: Jenck fullname: Jenck, François – sequence: 6 givenname: Frederick J surname: Monsma fullname: Monsma, Frederick J – sequence: 7 givenname: Jürgen surname: Wichmann fullname: Wichmann, Jürgen – sequence: 8 givenname: Frank M surname: Dautzenberg fullname: Dautzenberg, Frank M |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1345474$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10753470$$D View this record in MEDLINE/PubMed |
| BookMark | eNqN0c1uEzEQAGALFdG0cOAF0B4AtYIl_tlde49R1FCkqCmhVNwsr3fcOCR2am8EfXscbUgl4MDJI803I8_MCTpy3gFCLwn-QDAlw-W6rgmh9f0TNCAlxXkhcHGEBhhTmtOKsmN0EuMSY8wIZc_QMcG8ZAXHAzS_tHeLfGSMdbZ7eJ9deZdfw6azLWSjO-9s7GJmfMi6BWSz-ZRkZ7OwWShnXTb5PLzy2uodd-fZHHaRD8_RU6NWEV7s31P0dXJxM77Mp7OPn8ajaa6Kqu5yoE2tmFGECNICAyIqDppgIbjmpTY0JRhvjOGtVq2gglEDogBD2raiDWWn6G3fdxP8_RZiJ9c2alitlAO_jZLTskiDigRf7eG2WUMrN8GuVXiQv7eQwOs9UFGrlQnKaRsfHSvKgheJvevZD2i8idqC03BQabtYVKymu4Dsmor_12Pbqc56N_Zb16XSYV-qg48xgJF6n--Csqv0cbm7uzzcPVWc_1HxOOTfNu9tui38PEAVvsuKM17Km-svkk1uWX37jUqW_JveKx3l0m-DS1f9R99fE4fD0Q |
| CODEN | JMCMAR |
| CitedBy_id | crossref_primary_10_1039_C4CC08255A crossref_primary_10_1248_cpb_53_1270 crossref_primary_10_1261_rna_5186504 crossref_primary_10_1021_acs_jmedchem_5b01499 crossref_primary_10_1021_np030258d crossref_primary_10_1016_j_bmcl_2008_05_036 crossref_primary_10_1039_C4OB00709C crossref_primary_10_1016_j_bmcl_2004_08_001 crossref_primary_10_1021_acs_orglett_8b00951 crossref_primary_10_1371_journal_pone_0203021 crossref_primary_10_1111_bph_14893 crossref_primary_10_1034_j_1399_3011_2003_00077_x crossref_primary_10_1016_S1367_5931_00_00203_9 crossref_primary_10_1016_j_bmc_2006_11_030 crossref_primary_10_3390_molecules27030595 crossref_primary_10_1016_j_neuropharm_2005_01_020 crossref_primary_10_1007_s40265_023_01878_5 crossref_primary_10_1021_ci500291a crossref_primary_10_1016_j_bmc_2005_08_049 crossref_primary_10_1016_j_bmcl_2009_04_022 crossref_primary_10_1002_med_20197 crossref_primary_10_1016_j_bmcl_2006_03_086 crossref_primary_10_1016_S0022_3565_24_29443_X crossref_primary_10_3390_ijms12128961 crossref_primary_10_1016_j_ejphar_2010_07_036 crossref_primary_10_1111_cbdd_12505 crossref_primary_10_1021_jm070763y crossref_primary_10_1016_S0024_3205_02_01477_7 crossref_primary_10_1016_j_ejphar_2015_01_049 crossref_primary_10_1016_j_bmcl_2005_09_075 crossref_primary_10_1208_aapsj070234 crossref_primary_10_1016_S0968_0896_01_00085_2 crossref_primary_10_1111_j_1527_3458_2007_00007_x crossref_primary_10_1016_j_ejphar_2018_05_005 crossref_primary_10_1517_13543776_11_4_525 crossref_primary_10_1016_j_bmcl_2008_12_092 crossref_primary_10_1016_S0960_894X_02_00652_2 crossref_primary_10_1016_j_bmcl_2003_11_083 crossref_primary_10_1016_j_bmcl_2013_03_101 crossref_primary_10_1021_jm034249d crossref_primary_10_1016_S0304_3940_02_00259_8 crossref_primary_10_1002_chem_201804735 crossref_primary_10_1039_c4md00082j crossref_primary_10_1016_j_bmcl_2006_03_094 crossref_primary_10_1016_j_tet_2005_05_030 crossref_primary_10_1016_j_bmcl_2003_09_068 crossref_primary_10_1007_s43440_019_00039_4 crossref_primary_10_1016_j_pharmthera_2021_107982 crossref_primary_10_1021_acs_joc_9b01128 crossref_primary_10_1016_j_pharmthera_2013_10_011 crossref_primary_10_1002_chin_200028149 crossref_primary_10_1016_j_bcp_2005_02_014 crossref_primary_10_1039_D4MD00747F crossref_primary_10_1038_sj_bjp_0707598 crossref_primary_10_1016_S0014_2999_01_01282_1 crossref_primary_10_1517_13543771003602004 crossref_primary_10_1016_j_neuropharm_2016_02_003 crossref_primary_10_1016_j_npep_2020_102059 crossref_primary_10_1016_S0024_3205_03_00387_4 crossref_primary_10_1523_JNEUROSCI_6408_11_2012 |
| Cites_doi | 10.1016/0014-5793(94)00561-3 10.1126/science.270.5237.792 10.1016/0306-4522(96)00338-7 10.1016/0014-2999(77)90025-5 10.1097/00001756-199904060-00041 10.1016/S0014-2999(96)00707-8 10.1016/S0014-2999(97)01128-X 10.1021/jo01275a069 10.1111/j.1432-1033.1994.00917.x 10.1021/jo00119a008 10.1016/S0006-8993(99)01337-2 10.1016/0167-0115(94)90431-6 10.1073/pnas.94.26.14854 10.1016/S0006-8993(97)01406-6 10.1016/S0024-3205(99)00149-6 10.1016/S0166-2236(97)01204-6 10.1097/00001756-199609020-00012 10.1021/jo00074a008 10.1016/S0024-3205(97)00087-8 10.1016/0014-5793(94)80235-1 10.1021/jm970805q 10.1021/jo00295a061 10.1046/j.1471-4159.1995.64010034.x 10.1038/377535a0 10.1016/0014-5793(94)80603-9 10.1038/29073 10.1016/S0014-5793(98)00452-9 |
| ContentType | Journal Article |
| Copyright | Copyright © 2000 American Chemical Society 2000 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2000 American Chemical Society – notice: 2000 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION 17B 1KM BLEPL DTL EGQ FKBAJ IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1021/jm991129q |
| DatabaseName | Istex CrossRef Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2000 Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Web of Science MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1520-4804 |
| EndPage | 1338 |
| ExternalDocumentID | 10753470 1345474 000086392000010 10_1021_jm991129q ark_67375_TPS_3FV39VX2_3 a694708697 |
| Genre | Journal Article |
| GroupedDBID | - .K2 3EH 53G 55A 5GY 5RE 5VS 7~N 9M8 AABXI ABFLS ABMVS ABOCM ABPTK ABUCX ACGFS ACJ ACS ADKFC AEESW AENEX AFEFF AFFNX ALMA_UNASSIGNED_HOLDINGS ANTXH AQSVZ BAANH CS3 DU5 EBS ED ED~ EJD F5P GJ GNL IH9 IHE JG JG~ K2 L7B LG6 MVM NHB P2P ROL TN5 UI2 VF5 VG9 W1F WH7 X XFK YZZ ZE2 ZGI ZY4 --- -~X .GJ AAHBH AAYOK ABJNI ABQRX ABTAH ACGFO ADHLV AGXLV AHGAQ BSCLL CUPRZ GGK IH2 XSW YQT AAYXX ABBLG ABLBI ACRPL ADNMO AEYZD AGQPQ ANPPW CITATION 17B 1KM BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE .55 .HR 1KJ 1WB 3O- 4.4 6P2 6TJ ABHMW ADXHL IQODW OHT RNS UBC X7M CGR CUY CVF ECM EIF NPM VXZ YIN 7X8 |
| ID | FETCH-LOGICAL-a469t-e2b9a3fa1181de3e1867ec10887c75cf211837bff7dcad82832fe84ef1dd62b23 |
| IEDL.DBID | ACS |
| ISICitedReferencesCount | 76 |
| ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000086392000010 |
| ISSN | 0022-2623 |
| IngestDate | Fri Sep 05 08:19:34 EDT 2025 Wed Feb 19 02:34:02 EST 2025 Mon Jul 21 09:14:12 EDT 2025 Wed Aug 06 05:52:13 EDT 2025 Fri Sep 26 20:34:15 EDT 2025 Tue Jul 01 04:10:50 EDT 2025 Thu Apr 24 22:55:51 EDT 2025 Wed Oct 30 09:22:15 EDT 2024 Thu Aug 27 13:42:05 EDT 2020 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | ENDOGENOUS LIGAND ORL RECEPTOR KAPPA-OPIOID RECEPTORS PROTEIN-COUPLED RECEPTOR TISSUE DISTRIBUTION GENE FAMILY MOLECULAR-CLONING LONG-TERM POTENTIATION CDNA CLONING NOCICEPTIN/ORPHANIN FQ Agonist Nitrogen heterocycle Opioid receptor Lactam Non peptide compound Tricyclic compound In vitro Spiran Biological fixation Structure activity relation Bicyclic compound Aromatic compound Chemical synthesis Acenaphthylene derivatives |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
| MergedId | FETCHMERGED-LOGICAL-a469t-e2b9a3fa1181de3e1867ec10887c75cf211837bff7dcad82832fe84ef1dd62b23 |
| Notes | istex:C54FCA380687400B3680271D04471F79427ACF4A ark:/67375/TPS-3FV39VX2-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 10753470 |
| PQID | 72541078 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | istex_primary_ark_67375_TPS_3FV39VX2_3 proquest_miscellaneous_72541078 acs_journals_10_1021_jm991129q pubmed_primary_10753470 crossref_citationtrail_10_1021_jm991129q webofscience_primary_000086392000010 pascalfrancis_primary_1345474 webofscience_primary_000086392000010CitationCount crossref_primary_10_1021_jm991129q |
| ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ANTXH ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2000-04-06 |
| PublicationDateYYYYMMDD | 2000-04-06 |
| PublicationDate_xml | – month: 04 year: 2000 text: 2000-04-06 day: 06 |
| PublicationDecade | 2000 |
| PublicationPlace | WASHINGTON |
| PublicationPlace_xml | – name: WASHINGTON – name: Washington, DC – name: United States |
| PublicationTitle | Journal of medicinal chemistry |
| PublicationTitleAbbrev | J MED CHEM |
| PublicationTitleAlternate | J. Med. Chem |
| PublicationYear | 2000 |
| Publisher | American Chemical Society Amer Chemical Soc |
| Publisher_xml | – name: American Chemical Society – name: Amer Chemical Soc |
| References | Kolesnikov Y. A. (jm991129qb00005/jm991129qb00005_2) 1999; 64 Darland T. (jm991129qb00004/jm991129qb00004_3) 1998; 21 jm991129qb00011/jm991129qb00011_2 Cagniant P. (jm991129qb00021/jm991129qb00021_1) 1969; 985 Calo G. (jm991129qb00010/jm991129qb00010_1) 1998; 41 Mogil J. S. (jm991129qb00005/jm991129qb00005_5) 1996; 75 Grisel J. E. (jm991129qb00005/jm991129qb00005_4) 1996; 7 jm991129qb00011/jm991129qb00011_4 Yu T.-P. (jm991129qb00007/jm991129qb00007_2) 1997; 7 Rosowsky A. (jm991129qb00020/jm991129qb00020_2) 1968; 33 Mollereau C. (jm991129qb00001/jm991129qb00001_5) 1994; 341 Stjernloef P. (jm991129qb00020/jm991129qb00020_1) 1993; 28 Zaki P. A. (jm991129qb00004/jm991129qb00004_2) 1998; 4 Henderson G. (jm991129qb00004/jm991129qb00004_5) 1997; 18 Champion H. C. (jm991129qb00006/jm991129qb00006_2) 1997; 60 Manabe T. (jm991129qb00007/jm991129qb00007_1) 1998; 394 Ciccocioppo R. (jm991129qb00008/jm991129qb00008_1) 1999; 141 Reinscheid R. K. (jm991129qb00003/jm991129qb00003_1) 1995; 270 Chen Y. (jm991129qb00001/jm991129qb00001_1) 1994; 347 Keith D. (jm991129qb00001/jm991129qb00001_2) 1994; 54 Wang J. B. (jm991129qb00001/jm991129qb00001_4) 1994; 348 Yuan L. (jm991129qb00005/jm991129qb00005_1) 1999; 826 Lapalu S. (jm991129qb00023/jm991129qb00023_1) 1998; 427 Bunzow J. R. (jm991129qb00001/jm991129qb00001_7) 1994; 347 Taylor F. (jm991129qb00004/jm991129qb00004_1) 1998; 9 Wichmann J. (jm991129qb00019/jm991129qb00019_1) 1999; 9 Butour J.-L. (jm991129qb00002/jm991129qb00002_1) 1997; 321 Hao J.-X. (jm991129qb00005/jm991129qb00005_3) 1998; 76 Leysen J. (jm991129qb00012/jm991129qb00012_1) 1977; 43 Florin S. (jm991129qb00008/jm991129qb00008_3) 1996; 317 Fukuda K. (jm991129qb00001/jm991129qb00001_8) 1994; 343 Cheng Y.-C. (jm991129qb00018/jm991129qb00018_1) 1973; 22 Meunier J.-C. (jm991129qb00003/jm991129qb00003_2) 1995; 377 Olivier M. (jm991129qb00013/jm991129qb00013_1) 1974; 699 Lundstrom K. (jm991129qb00022/jm991129qb00022_1) 1994; 224 Giuliani S. (jm991129qb00006/jm991129qb00006_1) 1997; 333 Mamiya T. (jm991129qb00008/jm991129qb00008_2) 1998; 783 Lachowicz J. E. (jm991129qb00001/jm991129qb00001_6) 1995; 64 Bondavalli F. (jm991129qb00015/jm991129qb00015_1) 1979; 830 Olianas M. C. (jm991129qb00010/jm991129qb00010_2) 1999; 10 Bot G. (jm991129qb00023/jm991129qb00023_2) 1998; 285 Thompson A. S. (jm991129qb00016/jm991129qb00016_1) 1993; 58 Mattson R. J. (jm991129qb00014/jm991129qb00014_1) 1990; 55 Adam G. (jm991129qb00011/jm991129qb00011_1) 1998 Ozaki S. (jm991129qb00011/jm991129qb00011_3) 1998 Chiou L.-C. (jm991129qb00010/jm991129qb00010_3) 1999; 128 Tschaen D. M. (jm991129qb00017/jm991129qb00017_1) 1995; 60 Wick M. J. (jm991129qb00001/jm991129qb00001_3) 1994; 27 Meunier J.-C. (jm991129qb00004/jm991129qb00004_4) 1997; 340 Jenck F. (jm991129qb00009/jm991129qb00009_1) 1997; 94 Yu, TP (WOS:A1997WJ83900009) 1997; 7 Zaki, PA (WOS:000073929300012) 1998; 4 KEITH, D (WOS:A1994PT35800074) 1994; 54 (WOS:000086392000010.2) 1999 CAGNIANT, P (WOS:A1969C803600059) 1969 Mogil, JS (WOS:A1996VR67900001) 1996; 75 Wichmann, J (WOS:000082137300012) 1999; 9 STJERNLOF, P (WOS:A1993MC71600005) 1993; 28 Hao, JX (WOS:000075054700013) 1998; 76 Champion, HC (WOS:A1997WQ65500013) 1997; 60 Manabe, T (WOS:000075238700048) 1998; 394 LEYSEN, J (WOS:A1977DJ78100007) 1977; 43 Mamiya, T (WOS:000072484200008) 1998; 783 Bot, G (WOS:000074131400033) 1998; 285 Henderson, G (WOS:A1997XR95500006) 1997; 18 Chiou, LC (WOS:000082616900014) 1999; 128 WICK, MJ (WOS:A1994PP14300004) 1994; 27 Lapalu, S (WOS:000073727700031) 1998; 427 Olianas, MC (WOS:000079904900043) 1999; 10 MATTSON, RJ (WOS:A1990CZ61300060) 1990; 55 CHEN, Y (WOS:A1994NV02200038) 1994; 347 WANG, JB (WOS:A1994NW53400016) 1994; 348 BONDAVALLI, F (WOS:A1979HR54700024) 1979 Grisel, JE (WOS:A1996WD44100014) 1996; 7 Taylor, F (WOS:000076184100002) 1998; 9 Ciccocioppo, R (WOS:000078098000015) 1999; 141 LUNDSTROM, K (WOS:A1994PG32900015) 1994; 224 ROSOWSKY, A (WOS:A1968C073600069) 1968; 33 THOMPSON, AS (WOS:A1993MD98500008) 1993; 58 Meunier, JC (WOS:000071467100001) 1997; 340 REINSCHEID, RK (WOS:A1995TC71200038) 1995; 270 Butour, JL (WOS:A1997WL45600014) 1997; 321 LACHOWICZ, JE (WOS:A1995PX19900004) 1995; 64 Jenck, F (WOS:000071182800114) 1997; 94 (WOS:000086392000010.4) 1999 TSCHAEN, DM (WOS:A1995RK02700008) 1995; 60 OLIVIER, M (WOS:A1974S759800055) 1974 (WOS:000086392000010.1) 1998 Yuan, L (WOS:000080057100024) 1999; 826 Giuliani, S (WOS:A1997XV98700010) 1997; 333 Kolesnikov, YA (WOS:000080107200006) 1999; 64 CHENG, Y (WOS:A1973R295300018) 1973; 22 BUNZOW, JR (WOS:A1994NV02200039) 1994; 347 Florin, S (WOS:A1996WA25900002) 1996; 317 MOLLEREAU, C (WOS:A1994NB18900008) 1994; 341 FUKUDA, K (WOS:A1994NH51000009) 1994; 343 (WOS:000086392000010.3) 1998 Calo', G (WOS:000075647700008) 1998; 41 MEUNIER, JC (WOS:A1995RZ33600064) 1995; 377 Darland, T (WOS:000073353500012) 1998; 21 |
| References_xml | – volume: 347 start-page: 288 year: 1994 ident: jm991129qb00001/jm991129qb00001_7 publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)00561-3 – volume: 270 start-page: 794 year: 1995 ident: jm991129qb00003/jm991129qb00003_1 publication-title: Science doi: 10.1126/science.270.5237.792 – volume: 22 start-page: 3108 year: 1973 ident: jm991129qb00018/jm991129qb00018_1 publication-title: Biochem. Pharmacol. – volume: 9 start-page: 2348 year: 1999 ident: jm991129qb00019/jm991129qb00019_1 publication-title: Bioorg. Med. Chem. Lett. – ident: jm991129qb00011/jm991129qb00011_2 – volume: 75 start-page: 337 year: 1996 ident: jm991129qb00005/jm991129qb00005_5 publication-title: Neuroscience doi: 10.1016/0306-4522(96)00338-7 – volume: 43 start-page: 67 year: 1977 ident: jm991129qb00012/jm991129qb00012_1 publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(77)90025-5 – volume: 28 start-page: 701 year: 1993 ident: jm991129qb00020/jm991129qb00020_1 publication-title: Eur. J. Med. Chem. – volume: 10 start-page: 1131 year: 1999 ident: jm991129qb00010/jm991129qb00010_2 publication-title: NeuroReport doi: 10.1097/00001756-199904060-00041 – volume: 317 start-page: 13 year: 1996 ident: jm991129qb00008/jm991129qb00008_3 publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(96)00707-8 – volume-title: Preparation of 2-oxoimidazole derivatives as pharmaceuticals. PCT Int. Appl year: 1998 ident: jm991129qb00011/jm991129qb00011_3 – volume: 333 start-page: 179 year: 1997 ident: jm991129qb00006/jm991129qb00006_1 publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(97)01128-X – volume: 76 start-page: 393 year: 1998 ident: jm991129qb00005/jm991129qb00005_3 publication-title: Pain – volume: 33 start-page: 90 year: 1968 ident: jm991129qb00020/jm991129qb00020_2 publication-title: J. Org. Chem. doi: 10.1021/jo01275a069 – volume: 224 start-page: 921 year: 1994 ident: jm991129qb00022/jm991129qb00022_1 publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1994.00917.x – volume: 60 start-page: 4330 year: 1995 ident: jm991129qb00017/jm991129qb00017_1 publication-title: J. Org. Chem. doi: 10.1021/jo00119a008 – volume: 128 start-page: 107 year: 1999 ident: jm991129qb00010/jm991129qb00010_3 publication-title: Br. J. Pharmacol. – volume: 985 start-page: 991 year: 1969 ident: jm991129qb00021/jm991129qb00021_1 publication-title: Bull. Soc. Chim. Fr. – volume: 141 start-page: 224 year: 1999 ident: jm991129qb00008/jm991129qb00008_1 publication-title: Psychopharmacology – volume: 826 start-page: 334 year: 1999 ident: jm991129qb00005/jm991129qb00005_1 publication-title: Brain Res. doi: 10.1016/S0006-8993(99)01337-2 – volume: 830 start-page: 832 year: 1979 ident: jm991129qb00015/jm991129qb00015_1 publication-title: Synthesis – volume: 54 start-page: 144 year: 1994 ident: jm991129qb00001/jm991129qb00001_2 publication-title: Regul. Pept. doi: 10.1016/0167-0115(94)90431-6 – ident: jm991129qb00011/jm991129qb00011_4 – volume: 94 start-page: 14858 year: 1997 ident: jm991129qb00009/jm991129qb00009_1 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.94.26.14854 – volume: 347 start-page: 283 year: 1994 ident: jm991129qb00001/jm991129qb00001_1 publication-title: FEBS Lett. – volume: 783 start-page: 240 year: 1998 ident: jm991129qb00008/jm991129qb00008_2 publication-title: Brain Res. doi: 10.1016/S0006-8993(97)01406-6 – volume: 64 start-page: 2028 year: 1999 ident: jm991129qb00005/jm991129qb00005_2 publication-title: Life Sci. doi: 10.1016/S0024-3205(99)00149-6 – volume: 321 start-page: 103 year: 1997 ident: jm991129qb00002/jm991129qb00002_1 publication-title: Eur. J. Pharmacol. – volume: 21 start-page: 221 year: 1998 ident: jm991129qb00004/jm991129qb00004_3 publication-title: Trends Neurosci. doi: 10.1016/S0166-2236(97)01204-6 – volume: 699 start-page: 700 year: 1974 ident: jm991129qb00013/jm991129qb00013_1 publication-title: Bull. Soc. Chim. Fr. – volume: 7 start-page: 2129 year: 1996 ident: jm991129qb00005/jm991129qb00005_4 publication-title: NeuroReport doi: 10.1097/00001756-199609020-00012 – volume-title: psychiatric, neurological and physiological disorders. Eur. Pat. Appl year: 1998 ident: jm991129qb00011/jm991129qb00011_1 – volume: 58 start-page: 5888 year: 1993 ident: jm991129qb00016/jm991129qb00016_1 publication-title: J. Org. Chem. doi: 10.1021/jo00074a008 – volume: 60 start-page: L245 year: 1997 ident: jm991129qb00006/jm991129qb00006_2 publication-title: Life Sci. doi: 10.1016/S0024-3205(97)00087-8 – volume: 341 start-page: 38 year: 1994 ident: jm991129qb00001/jm991129qb00001_5 publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)80235-1 – volume: 41 start-page: 3366 year: 1998 ident: jm991129qb00010/jm991129qb00010_1 publication-title: J. Med. Chem. doi: 10.1021/jm970805q – volume: 55 start-page: 2554 year: 1990 ident: jm991129qb00014/jm991129qb00014_1 publication-title: J. Org. Chem. doi: 10.1021/jo00295a061 – volume: 64 start-page: 40 year: 1995 ident: jm991129qb00001/jm991129qb00001_6 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1995.64010034.x – volume: 377 start-page: 535 year: 1995 ident: jm991129qb00003/jm991129qb00003_2 publication-title: Nature doi: 10.1038/377535a0 – volume: 9 start-page: R70 year: 1998 ident: jm991129qb00004/jm991129qb00004_1 publication-title: NeuroReport – volume: 27 start-page: 44 year: 1994 ident: jm991129qb00001/jm991129qb00001_3 publication-title: Mol. Brain Res. – volume: 4 start-page: 184 year: 1998 ident: jm991129qb00004/jm991129qb00004_2 publication-title: Neuroscientist – volume: 343 start-page: 46 year: 1994 ident: jm991129qb00001/jm991129qb00001_8 publication-title: FEBS Lett. doi: 10.1016/0014-5793(94)80603-9 – volume: 18 start-page: 299 year: 1997 ident: jm991129qb00004/jm991129qb00004_5 publication-title: Trends Pharmacol. Sci. – volume: 394 start-page: 581 year: 1998 ident: jm991129qb00007/jm991129qb00007_1 publication-title: Nature doi: 10.1038/29073 – volume: 348 start-page: 79 year: 1994 ident: jm991129qb00001/jm991129qb00001_4 publication-title: FEBS Lett. – volume: 340 start-page: 15 year: 1997 ident: jm991129qb00004/jm991129qb00004_4 publication-title: Eur. J. Pharmacol. – volume: 7 start-page: 94 year: 1997 ident: jm991129qb00007/jm991129qb00007_2 publication-title: Hippocampus – volume: 427 start-page: 300 year: 1998 ident: jm991129qb00023/jm991129qb00023_1 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(98)00452-9 – volume: 285 start-page: 1218 year: 1998 ident: jm991129qb00023/jm991129qb00023_2 publication-title: J. Pharmacol. Exp. Ther. – volume: 60 start-page: PL241 year: 1997 ident: WOS:A1997WQ65500013 article-title: Nociceptin, and endogenous ligand for the ORL(1) receptor, has novel hypotensive activity in the rat publication-title: LIFE SCIENCES – volume: 141 start-page: 220 year: 1999 ident: WOS:000078098000015 article-title: Effect of nociceptin on alcohol intake in alcohol preferring rats publication-title: PSYCHOPHARMACOLOGY – volume: 343 start-page: 42 year: 1994 ident: WOS:A1994NH51000009 article-title: CDNA CLONING AND REGIONAL DISTRIBUTION OF A NOVEL MEMBER OF THE OPIOID RECEPTOR FAMILY publication-title: FEBS LETTERS – volume: 341 start-page: 33 year: 1994 ident: WOS:A1994NB18900008 article-title: ORL1, A NOVEL MEMBER OF THE OPIOID RECEPTOR FAMILY - CLONING, FUNCTIONAL EXPRESSION AND LOCALIZATION publication-title: FEBS LETTERS – volume: 270 start-page: 792 year: 1995 ident: WOS:A1995TC71200038 article-title: ORPHANIN-FQ - A NEUROPEPTIDE THAT ACTIVATES AN OPIOID-LIKE G-PROTEIN-COUPLED RECEPTOR publication-title: SCIENCE – volume: 347 start-page: 284 year: 1994 ident: WOS:A1994NV02200039 article-title: MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE publication-title: FEBS LETTERS – volume: 28 start-page: 693 year: 1993 ident: WOS:A1993MC71600005 article-title: 5, 6, 7 AND 8-AMINO-2-(N,N-DI-N-PROPYLAMINO)-1,2,3,4-TETRAHYDRONAPHTHALENES - CENTRALLY ACTING DA AND 5-HT(1A) AGONISTS publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY – volume: 76 start-page: 385 year: 1998 ident: WOS:000075054700013 article-title: Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation publication-title: PAIN – volume: 41 start-page: 3360 year: 1998 ident: WOS:000075647700008 article-title: Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist publication-title: JOURNAL OF MEDICINAL CHEMISTRY – volume: 427 start-page: 296 year: 1998 ident: WOS:000073727700031 article-title: Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A publication-title: FEBS LETTERS – volume: 9 start-page: 2343 year: 1999 ident: WOS:000082137300012 article-title: 8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS – year: 1998 ident: WOS:000086392000010.3 – volume: 43 start-page: 253 year: 1977 ident: WOS:A1977DJ78100007 article-title: DIFFERENTIATION OF OPIATE AND NEUROLEPTIC RECEPTOR-BINDING IN RAT-BRAIN publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – volume: 348 start-page: 75 year: 1994 ident: WOS:A1994NW53400016 article-title: CDNA CLONING OF AN ORPHAN OPIATE RECEPTOR GENE FAMILY MEMBER AND ITS SPLICE VARIANT publication-title: FEBS LETTERS – volume: 21 start-page: 215 year: 1998 ident: WOS:000073353500012 article-title: Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more publication-title: TRENDS IN NEUROSCIENCES – volume: 317 start-page: 9 year: 1996 ident: WOS:A1996WA25900002 article-title: Nociceptin stimulates locomotion and exploratory behaviour in mice publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – volume: 58 start-page: 5886 year: 1993 ident: WOS:A1993MD98500008 article-title: DIRECT CONVERSION OF ACTIVATED ALCOHOLS TO AZIDES USING DIPHENYL PHOSPHORAZIDATE - A PRACTICAL ALTERNATIVE TO MITSUNOBU CONDITIONS publication-title: JOURNAL OF ORGANIC CHEMISTRY – year: 1999 ident: WOS:000086392000010.2 – volume: 4 start-page: 172 year: 1998 ident: WOS:000073929300012 article-title: ORL-1: An awkward child of the opioid receptor family publication-title: NEUROSCIENTIST – volume: 64 start-page: 34 year: 1995 ident: WOS:A1995PX19900004 article-title: MOLECULAR-CLONING OF A NOVEL G-PROTEIN-COUPLED RECEPTOR-RELATED TO THE OPIATE RECEPTOR FAMILY publication-title: JOURNAL OF NEUROCHEMISTRY – start-page: 830 year: 1979 ident: WOS:A1979HR54700024 article-title: REACTION OF TERPENOID NITRIMINES WITH SECONDARY-AMINES - NEW ROUTE TO TERPENOID ENAMINES publication-title: SYNTHESIS-STUTTGART – volume: 333 start-page: 177 year: 1997 ident: WOS:A1997XV98700010 article-title: Effect of nociceptin on heart rate and blood pressure in anaesthetized rats publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – volume: 64 start-page: 2021 year: 1999 ident: WOS:000080107200006 article-title: Peripheral orphanin FQ/Nociceptin analgesia in the mouse publication-title: LIFE SCIENCES – volume: 9 start-page: R65 year: 1998 ident: WOS:000076184100002 article-title: Nociceptin/orphanin FQ. A new opioid, a new analgesic? publication-title: NEUROREPORT – volume: 60 start-page: 4324 year: 1995 ident: WOS:A1995RK02700008 article-title: ASYMMETRIC-SYNTHESIS OF MK-0499 publication-title: JOURNAL OF ORGANIC CHEMISTRY – volume: 7 start-page: 88 year: 1997 ident: WOS:A1997WJ83900009 article-title: Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus publication-title: HIPPOCAMPUS – volume: 340 start-page: 1 year: 1997 ident: WOS:000071467100001 article-title: Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – start-page: 699 year: 1974 ident: WOS:A1974S759800055 article-title: STUDY OF HALOGENATED MONOMERS AND OF THEIR CATIONIC POLYMERIZATION .4. PREPARATION, CATIONIC HOMOPOLYMERIZATION AND COPOLYMERIZATION OF 4,7-DICHLOROINDENE publication-title: BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE PARTIE II-CHIMIE MOLECULAIRE ORGANIQUE ET BIOLOGIQUE – volume: 285 start-page: 1207 year: 1998 ident: WOS:000074131400033 article-title: Fentanyl and its analogs desensitize the cloned mu opioid receptor publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS – year: 1999 ident: WOS:000086392000010.4 – volume: 27 start-page: 37 year: 1994 ident: WOS:A1994PP14300004 article-title: ISOLATION OF A NOVEL CDNA-ENCODING A PUTATIVE MEMBRANE-RECEPTOR WITH HIGH HOMOLOGY TO THE CLONED MU-OPIOID, DELTA-OPIOID, AND KAPPA-OPIOID RECEPTORS publication-title: MOLECULAR BRAIN RESEARCH – volume: 394 start-page: 577 year: 1998 ident: WOS:000075238700048 article-title: Facilitation of long-term potentiation and memory in mice lacking nociception receptors publication-title: NATURE – volume: 75 start-page: 333 year: 1996 ident: WOS:A1996VR67900001 article-title: Orphanin FQ is a functional anti-opioid peptide publication-title: NEUROSCIENCE – volume: 321 start-page: 97 year: 1997 ident: WOS:A1997WL45600014 article-title: Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – start-page: 985 year: 1969 ident: WOS:A1969C803600059 article-title: CLEAVAGE AND MIGRATION OF TERTIOBUTYL GROUPS IN FRIEDEL-CRAFTS REACTION .I. SYNTHESIS OF TERTIOBUTYL SUBSTITUTED TETRALONES publication-title: BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE – volume: 783 start-page: 236 year: 1998 ident: WOS:000072484200008 article-title: Enhancement of spatial attention in nociceptin orphanin FQ receptor knockout mice publication-title: BRAIN RESEARCH – volume: 18 start-page: 293 year: 1997 ident: WOS:A1997XR95500006 article-title: The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ publication-title: TRENDS IN PHARMACOLOGICAL SCIENCES – volume: 128 start-page: 103 year: 1999 ident: WOS:000082616900014 article-title: [Phe(1)psi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray publication-title: BRITISH JOURNAL OF PHARMACOLOGY – volume: 94 start-page: 14854 year: 1997 ident: WOS:000071182800114 article-title: Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA – volume: 22 start-page: 3099 year: 1973 ident: WOS:A1973R295300018 article-title: RELATIONSHIP BETWEEN INHIBITION CONSTANT (K1) AND CONCENTRATION OF INHIBITOR WHICH CAUSES 50 PER CENT INHIBITION (I50) OF AN ENZYMATIC-REACTION publication-title: BIOCHEMICAL PHARMACOLOGY – volume: 7 start-page: 2125 year: 1996 ident: WOS:A1996WD44100014 article-title: Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide publication-title: NEUROREPORT – volume: 826 start-page: 330 year: 1999 ident: WOS:000080057100024 article-title: Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats publication-title: BRAIN RESEARCH – volume: 54 start-page: 143 year: 1994 ident: WOS:A1994PT35800074 article-title: ISOLATION OF CDNA CLONES HOMOLOGOUS TO OPIOID RECEPTORS publication-title: REGULATORY PEPTIDES – volume: 347 start-page: 279 year: 1994 ident: WOS:A1994NV02200038 article-title: MOLECULAR-CLONING, TISSUE DISTRIBUTION AND CHROMOSOMAL LOCALIZATION OF A NOVEL MEMBER OF THE OPIOID RECEPTOR GENE FAMILY publication-title: FEBS LETTERS – volume: 224 start-page: 917 year: 1994 ident: WOS:A1994PG32900015 article-title: HIGH-LEVEL EXPRESSION OF THE HUMAN NEUROKININ-1 RECEPTOR IN MAMMALIAN-CELL LINES USING THE SEMLIKI FOREST VIRUS EXPRESSION SYSTEM publication-title: EUROPEAN JOURNAL OF BIOCHEMISTRY – volume: 55 start-page: 2552 year: 1990 ident: WOS:A1990CZ61300060 article-title: AN IMPROVED METHOD FOR REDUCTIVE ALKYLATION OF AMINES USING TITANIUM(IV) ISOPROPOXIDE AND SODIUM CYANOBOROHYDRIDE publication-title: JOURNAL OF ORGANIC CHEMISTRY – volume: 10 start-page: 1127 year: 1999 ident: WOS:000079904900043 article-title: [Phe(1)Phi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells publication-title: NEUROREPORT – volume: 33 start-page: 4288 year: 1968 ident: WOS:A1968C073600069 article-title: SYNTHESIS OF NEW CHLORINE-SUBSTITUTED DERIVATIVES OF 2-TETRALONE publication-title: JOURNAL OF ORGANIC CHEMISTRY – year: 1998 ident: WOS:000086392000010.1 – volume: 377 start-page: 532 year: 1995 ident: WOS:A1995RZ33600064 article-title: ISOLATION AND STRUCTURE OF THE ENDOGENOUS AGONIST OF OPIOID RECEPTOR-LIKE ORL(1) RECEPTOR publication-title: NATURE |
| SSID | ssj0003123 |
| Score | 1.9265296 |
| Snippet | The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1a, as a high-affinity ligand for the human... The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro [4.5]decan-4-one, 1a, as a high-affinity ligand for the human... |
| Source | Web of Science |
| SourceID | proquest pubmed pascalfrancis webofscience crossref istex acs |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1329 |
| SubjectTerms | Binding, Competitive Biological and medical sciences Cell Line Chemistry, Medicinal Humans Imidazoles - chemical synthesis Imidazoles - chemistry Imidazoles - pharmacology Life Sciences & Biomedicine Ligands Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Pharmacology & Pharmacy Pharmacology. Drug treatments Radioligand Assay Receptors, Opioid - agonists Science & Technology Spiro Compounds - chemical synthesis Spiro Compounds - chemistry Spiro Compounds - pharmacology Structure-Activity Relationship |
| Title | High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor |
| URI | http://dx.doi.org/10.1021/jm991129q https://api.istex.fr/ark:/67375/TPS-3FV39VX2-3/fulltext.pdf http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000086392000010 https://www.ncbi.nlm.nih.gov/pubmed/10753470 https://www.proquest.com/docview/72541078 |
| Volume | 43 |
| WOS | 000086392000010 |
| WOSCitedRecordID | wos000086392000010 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9RAEJ8gPOiLKCoWBDdKLpiw0N1-P15OL8ToccJB7q3ZdncNoi1cewn41zvbj7sjnh9vTTr9mpnd-U139jcAe8y2RWhLQTXXPnVVkNAw9STFUKkVC3VkK_Mf8vPAPz53P4698Qq8_cMKPmdH334ghMGodPMA1riP8cXgn97ZbLp1GHdaSnCOwbylD1q81ISetLgXetaMFm9NKaQoUBu6bmOxDGcuDUlV-Omvw_t2E09ddXJ1OC2Tw_Tn75yOf_uyJ_C4gZ-kW_vLU1hR2QY87LVd3zagM6y5rO8OyGi-Nas4IB0ynLNc3z2DU1MhQrtaX-KkgNKDPKNDUyIjFel-zQ0hb0EQERNEmOTk9BMj-ydoU5FdZqT_5WiATlFV1GTvCEJXPMonz-G8_2HUO6ZNgwYqMKsuqeJJJBwtzOZVqRxlyPFUyszElQZeqjG5xPw30TqQqZCh6YqkVegqzaT0ecKdF7Ca5Zl6CcRD0wVRkjDtR27EbWEyT-ZKRE8BPsKzYBctGDcDrIirtXOOuUurQwv2W-PGaUNvbrpsfF8m-mYmel1zeiwT6lQeMpMQkytTBBd48Wh4Fjv9Cye6GPPYsWDnngvNb-kYsjTXgtetS8VoS7MeIzKVT4s4wOQcs-_Qgs3a0xbeBrNIN7At2Ft0vdn5CukjtuTV4gyKsf8R6zVqMWwH5da_FLoNj2raAZfa_itYLSdTtYMArEx2qwH4C6fBJe0 |
| linkProvider | American Chemical Society |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED_B9jBe-BgwAmyz0FQNad5i5_uxqqgKdF3ZuqlvkZPYaAwSaFKJ8ddzdpK2Q5XYW6RcHOd89v0uPv8O4IDZtgjtTFDFlU9dGSQ0TL2MoqtUkoUqsqX-D3k68geX7qepN21ocvRZGOxEiS2VZhN_yS7ATr79QCSDzunXQ9j0fNfXZRq6vYvFqusw7rTM4Bx9essitPqo9kBpeccDbWpl_tYZkaJEpai6msU6uLnWMxkv1H9SlzMy_TfJJzfH8yo5Tv_8Q-14vw98Co8bMEq6tfU8gwcy34atXlsDbhs645rZ-vaITJYHtcoj0iHjJef17XM41_kitKvUNS4RKD0qcjrWCTOZJN2vhabnLQniY4J4k5ydDxk5PMMRFvl1TvpfTkZoIia_Jn9PEMjiVTF7AZf9D5PegDblGqjAGLuikieRcJTQR1kz6UhNlSdTppexNPBShaEmRsOJUkGWiizUNZKUDF2pWJb5POHOS9jIi1y-AuLhCAZRkjDlR27EbaHjUOZmiKUCfIVnwR6qMG6mWxmbnXSOkUyrQwsO2zGO04bsXNfc-L5O9N1C9GfN8LFOqGMMZSEhZjc6JS7w4sn4Inb6V050NeWxY8HuHUtaNulo6jTXgv3WsmIcS707I3JZzMs4wFAdY_HQgp3a4FZ6gzGlG9gWHKxa4OK-wf2INLnZqkExdh-xXqMWzX1Qvf6fQvdhazA5HcbDj6PPb-BRTUjgUtt_CxvVbC53EZpVyZ6Zk38BJE4uTw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD6CTQJeuIzLAmyz0FQNadli5_5YFaIBoy1bN_UtcmIbbYNkNKnE-PUc59YOVWJvlXqaJsfHPt8XH38HYJdaFg8swU3FlGc60k_MIHWFialSSRqo0JL6PeTXoXd05nyeutOGKOqzMHgTBV6pqDbx9ay-FqpRGKCHlz8RzWCC-nUf1hGIUN2qoT847VZemzK7VQdnmNdbJaHln-oslBa3stC6duhvXRXJC3SMqjtarIKcK7NTlYmiJzDqnqEqQLk6mJfJQfrnH3nHuz_kU3jcgFLSr6PoGdyT2QY8HLS94DagN64Vrm_2yWRxYKvYJz0yXmhf3zyHE103YvaVusClAq2HeWaOdeGMkKT_PdcyvQVBnEwQd5LRyTEleyMcaZ5dZCT6djjEUKnqbLL3BAEtfspnL-As-jgZHJlN2waTI9cuTcmSkNuK6yOtQtpSS-bJlOrlLPXdVCHlRFacKOWLlItA90pSMnCkokJ4LGH2S1jL8kxuAnFxFP0wSajyQidkFtd8lDoCMZWPf-EasI1ujJtpV8TVjjpDRtP60IC9dpzjtBE91703fqwyfdeZXtdKH6uMelWwdBZ8dqVL43w3noxPYzs6t8PzKYttA7ZuRdPikraWUHMM2GmjK8ax1Ls0PJP5vIh9pOzIyQMDXtVBt3Q3yC0d3zJgdzkKu-8r_I-Ik1VbNmhG72I2aNyiNRDK1_9z6A48GH-I4uNPwy9v4FGtS-CYlvcW1srZXG4hQiuT7Wpa_gXbOzDJ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-Affinity%2C+Non-Peptide+Agonists+for+the+ORL1+%28Orphanin+FQ%2FNociceptin%29+Receptor&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=R%C3%B6VER%2C+Stephan&rft.au=ADAM%2C+Geo&rft.au=CESURA%2C+Andrea+M.&rft.au=GALLEY%2C+Guido&rft.date=2000-04-06&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=43&rft.issue=7&rft.spage=1329&rft.epage=1338&rft_id=info:doi/10.1021%2Fjm991129q&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_TPS_3FV39VX2_3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |